More About NanoTherapies: |
NanoTherapies develops life-changing therapies for cancer treatment based on an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. NanoTherapies was formed in an equity partnership with Keystone Nano (KN) to commercialize and fund further development of intellectual properties and patents developed by Keystone Nano creating distinctive cancer therapies by embedding pharmaceuticals inside smart calcium phosphate particles developed at Penn State University. The company has the support of Keystone Nano, the Ben Franklin Partnership, Penn State, Hershey Medical, and a major corporate partner, Nalco. Given the status of competitors in this field NanoTherapies has the opportunity to commercialize an important Cancer Therapeutic through the application of a novel nanotechnology.
|
|---|
